Next Article in Journal
Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis
Previous Article in Journal
Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(4), 477; https://doi.org/10.3390/pharmaceutics17040477
Action Date Notes Link
article xml file uploaded 6 April 2025 10:54 CEST Original file -
article xml uploaded. 6 April 2025 10:54 CEST Update -
article pdf uploaded. 6 April 2025 10:54 CEST Version of Record https://www.mdpi.com/1999-4923/17/4/477/pdf-vor
article supplementary file uploaded. 6 April 2025 10:54 CEST - https://www.mdpi.com/1999-4923/17/4/477#supplementary
article html file updated 6 April 2025 10:58 CEST Original file -
article xml file uploaded 6 April 2025 11:49 CEST Update -
article xml uploaded. 6 April 2025 11:49 CEST Update -
article pdf uploaded. 6 April 2025 11:49 CEST Updated version of record https://www.mdpi.com/1999-4923/17/4/477/pdf-vor
article html file updated 6 April 2025 11:50 CEST Update -
article html file updated 7 April 2025 03:59 CEST Update -
article xml file uploaded 8 April 2025 09:48 CEST Update -
article xml uploaded. 8 April 2025 09:48 CEST Update https://www.mdpi.com/1999-4923/17/4/477/xml
article pdf uploaded. 8 April 2025 09:48 CEST Updated version of record https://www.mdpi.com/1999-4923/17/4/477/pdf
article html file updated 8 April 2025 09:48 CEST Update https://www.mdpi.com/1999-4923/17/4/477/html
Back to TopTop